News
Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.
As appetite-suppressing drugs change the way people eat, businesses are adapting to GLP-1 users by offering smaller portions ...
Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.
A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...
Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...
The small study followed patients for six months and found that 54 percent experienced a reduction in their symptoms after taking a GLP-1RA. Most of the patients had type 2 diabetes and the median BMI ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...
As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...
Coastal Carolina University is one of 28 teams across the country being featured on limited edition Bud Light cans, which is ...
Krystal Biotech has suspended a study of a skin cancer therapy called KB707, citing a shift in the approach toward drug approvals by the regulatory agency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results